PAR — Par Drugs and Chemicals Balance Sheet
0.000.00%
- IN₹1.20bn
- IN₹924.55m
- IN₹1.01bn
Annual balance sheet for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | PRESS |
Standards: | — | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 212 | 162 | 222 | 367 | 276 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 125 | 217 | 212 | 185 | 211 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 412 | 436 | 494 | 596 | 549 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 344 | 344 | 387 | 413 | 389 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 764 | 787 | 889 | 1,016 | 1,194 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 160 | 149 | 140 | 124 | 166 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 242 | 188 | 176 | 160 | 204 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 522 | 599 | 712 | 856 | 990 |
Total Liabilities & Shareholders' Equity | 764 | 787 | 889 | 1,016 | 1,194 |
Total Common Shares Outstanding |